GlassScriptPhysician profile
Joni Lyn Ruffner
NPI 1245623230
$1,720.87
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $669 · 2022: $873 · 2023: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $178.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $490.77 | 2022 | |
| Janssen Pharmaceuticals, INC | $400.95 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $208.56 | 2021-2023 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Bayer Healthcare Pharmaceuticals INC. | $124.99 | 2023 | |
| Inari Medical, INC. | $120.58 | 2021 | |
| Mylan Specialty L.P. | $78.48 | 2021-2022 | |
| Abbvie INC. | $57.08 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $45.77 | 2021-2022 | |
| Baxter Healthcare | $38.10 | 2022 | |
| Astellas Pharma US INC | $24.53 | 2022 | |
| Amgen INC. | $21.00 | 2022 | |
| Cook Medical LLC | $19.40 | 2021 | |
| Abbott Laboratories | $19.15 | 2023 | Amplatzer |
| Argon Medical Devices, INC. | $17.26 | 2022 | |
| Glaxosmithkline, LLC. | $15.22 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $14.49 | 2022 | |
| Medtronic, INC. | $12.37 | 2022 | |
| Ethicon US, LLC | $12.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joni Ruffner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.